Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Hemopneumothorax, Pneumothorax

In brief

The purpose of this study is to examine the efficacy of prophylactic antibiotics in patients with chest tubes for management of thoracic injuries in the reduction of the incidence of empyema as compared to placebo.

Key facts

Study ID

NCT01127880

Run by

St. Luke's Hospital, Pennsylvania

People needed

50

Starts

2005-07-01

Expected to finish

2009-12-01

Last updated by the study team

2010-05-21

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 16 years of age.
• Admission to Trauma, General Surgery, and/or Surgical Critical Care services.
• Traumatic pneumothorax, hemothorax or hemopneumothorax

You may not qualify if…

• Pregnancy
• Open fracture
• Immunocompromised
• Require antibiotics for treatment of other injuries
• Chest tube placement greater than 72hrs after admission

Where it is running

• St. Luke's Hospital and Health Network — Bethlehem, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.